thymol has been researched along with Candida Infection in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, I; Jafri, H | 1 |
| Camargo, SEA; de Oliveira, JR; de Oliveira, LD; Figueira, LW; Meccatti, VM; Sper, FL | 1 |
| Khosravi, AR; Sharifzadeh, A; Shirzadi, H; Shokri, H | 1 |
| Shu, C; Sun, L; Zhang, W | 1 |
| Cavaleiro, C; Costa-de-Oliveira, S; Gonçalves, MJ; Martinez-de-Oliveira, J; Palmeira, A; Pina-Vaz, C; Pinto, E; Rodrigues, A; Salgueiro, L | 1 |
| Darouiche, RO; Mansouri, MD | 1 |
6 other study(ies) available for thymol and Candida Infection
| Article | Year |
|---|---|
Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Topics: Antifungal Agents; Biofilms; Candida albicans; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Humans; Microbial Sensitivity Tests; Oils, Volatile; Plant Oils; Thymol; Thymus Plant | 2020 |
Thymus vulgaris L. and thymol assist murine macrophages (RAW 264.7) in the control of in vitro infections by Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans.
Topics: Animals; Candida albicans; Candidiasis; Cytokines; Immunologic Factors; Macrophages; Mice; Nitric Oxide; Phagocytosis; Plant Extracts; Pseudomonas aeruginosa; Pseudomonas Infections; RAW 264.7 Cells; Staphylococcal Infections; Staphylococcus aureus; Thymol; Thymus Plant | 2017 |
Potential effect of 2-isopropyl-5-methylphenol (thymol) alone and in combination with fluconazole against clinical isolates of Candida albicans, C. glabrata and C. krusei.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Humans; Microbial Sensitivity Tests; Phenols; Thymol | 2018 |
Thymol has antifungal activity against Candida albicans during infection and maintains the innate immune response required for function of the p38 MAPK signaling pathway in Caenorhabditis elegans.
Topics: Animals; Antifungal Agents; Biofilms; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Candida albicans; Candidiasis; Cell Growth Processes; Immunity, Innate; Intestines; Mitogen-Activated Protein Kinases; Mutation; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Receptor, EphA4; Signal Transduction; Thymol; Thymus Plant | 2016 |
Antifungal activity of the essential oil of Thymus pulegioides on Candida, Aspergillus and dermatophyte species.
Topics: Antifungal Agents; Arthrodermataceae; Aspergillosis; Aspergillus; Candida; Candidiasis; Cymenes; Dermatomycoses; Ergosterol; Humans; Microbial Sensitivity Tests; Monoterpenes; Oils, Volatile; Plant Components, Aerial; Plant Oils; Plants, Medicinal; Portugal; Spectrophotometry; Thymol; Thymus Plant | 2006 |
In-vitro activity and in-vivo efficacy of catheters impregnated with chloroxylenol and thymol against uropathogens.
Topics: Animals; Anti-Infective Agents, Local; Bacteria; Bacterial Infections; Candida albicans; Candidiasis; Catheters, Indwelling; Drug Delivery Systems; Female; Microbial Sensitivity Tests; Rabbits; Specific Pathogen-Free Organisms; Thymol; Time Factors; Urinary Catheterization; Urinary Tract Infections; Xylenes | 2008 |